The following pages link to Statistics in Medicine (Q57552):
Displaying 50 items.
- Adjusted restricted mean survival times in observational studies (Q6625176) (← links)
- Participants' outcomes gone missing within a network of interventions: Bayesian modeling strategies (Q6625180) (← links)
- The population-attributable fraction for time-dependent exposures and competing risks -- A discussion on estimands (Q6625185) (← links)
- Estimation of the adjusted cause-specific cumulative probability using flexible regression models for the cause-specific hazards (Q6625186) (← links)
- A latent variable approach to potential outcomes for emergency department admission decisions (Q6625188) (← links)
- Maximum diversity weighting for biomarkers with application in HIV-1 vaccine studies (Q6625189) (← links)
- Cloud-based simulation studies in \textbf{R} -- a tutorial on using doRedis with Amazon spot fleets (Q6625191) (← links)
- Analysis of clustered failure time data with cure fraction using copula (Q6625192) (← links)
- Subgroup identification using covariate-adjusted interaction trees (Q6625193) (← links)
- Adaptive group-sequential design with population enrichment in phase 3 randomized controlled trials with two binary co-primary endpoints (Q6625194) (← links)
- Stochastic approximation EM for large-scale exploratory IRT factor analysis (Q6625196) (← links)
- A parametric meta-analysis (Q6625197) (← links)
- Frequentist operating characteristics of Bayesian optimal designs via simulation (Q6625198) (← links)
- Estimating person parameters via item response model and simple sum score in small samples with few polytomous items: a simulation study (Q6625201) (← links)
- The integrated calibration index (ICI) and related metrics for quantifying the calibration of logistic regression models (Q6625202) (← links)
- Dependence modeling for multi-type recurrent events via copulas (Q6625203) (← links)
- Statistical inference of the relative concentration index for complex surveys (Q6625205) (← links)
- Assessing the impact of sleep time on truck driver performance using a recurrent event model (Q6625207) (← links)
- Comparison of novel methods in two-way enriched clinical trial design (Q6625210) (← links)
- Clinical heterogeneity in random-effect meta-analysis: between-study boundary estimate problem (Q6625211) (← links)
- Estimation and prediction for a mechanistic model of measles transmission using particle filtering and maximum likelihood estimation (Q6625213) (← links)
- A variational approach to optimal two-stage designs (Q6625214) (← links)
- Combined criteria for dose optimisation in early phase clinical trials (Q6625215) (← links)
- \(P\) value functions: an underused method to present research results and to promote quantitative reasoning (Q6625218) (← links)
- Randomization: the forgotten component of the randomized clinical trial (Q6625510) (← links)
- Discussion of ``Randomization: the forgotten component of the randomized clinical trial'' (Q6625511) (← links)
- Commentary on: ``Randomization: the forgotten component of the randomized clinical trial'' (Q6625512) (← links)
- Reflections on: ``Randomization: the forgotten component of the randomized clinical trial'' (Q6625513) (← links)
- Discussion of: ``Randomization: the forgotten component of the randomized clinical trial'' (Q6625514) (← links)
- Commentary: Ancillarity contra randomization as a basis for inference (Q6625515) (← links)
- Rejoinder (Q6625516) (← links)
- Half blind superiority tests for clinical trials of anti-infective drugs (Q6625517) (← links)
- Improving the efficiency of individually randomized clinical trials by staggering the introduction of the intervention (Q6625520) (← links)
- Graphing the win ratio and its components over time (Q6625521) (← links)
- Statistical inferences of extended concentration indices for directly standardized rates (Q6625523) (← links)
- A Bayesian latent class approach for EHR-based phenotyping (Q6625530) (← links)
- Power analysis for multivariable Cox regression models (Q6625531) (← links)
- Evaluating classification performance of biomarkers in two-phase case-control studies (Q6625532) (← links)
- A Bayesian approach for correcting exposure misclassification in meta-analysis (Q6625533) (← links)
- Respondent-driven sampling and the homophily configuration graph (Q6625534) (← links)
- Practical and statistical challenges in driving research (Q6625535) (← links)
- Semiparametric Bayesian models for evaluating time-variant driving risk factors using naturalistic driving data and case-crossover approach (Q6625536) (← links)
- Innovative modeling of naturalistic driving data: inference and prediction (Q6625537) (← links)
- Theory of general balance applied to step wedge designs (Q6625538) (← links)
- Design and monitoring of survival trials in complex scenarios (Q6625542) (← links)
- Combining multiple imputation and bootstrap in the analysis of cost-effectiveness trial data (Q6625543) (← links)
- Adaptive protocols based on predictions from a mechanistic model of the effect of IL7 on CD4 counts (Q6625544) (← links)
- Application of kriging models for a drug combination experiment on lung cancer (Q6625545) (← links)
- Investigation of one-stage meta-analysis methods for joint longitudinal and time-to-event data through simulation and real data application (Q6625549) (← links)
- Investigating hospital heterogeneity with a competing risks frailty model (Q6625551) (← links)
